US Stock MarketDetailed Quotes

PULM Pulmatrix

Watchlist
  • 2.130
  • +0.070+3.40%
Close Nov 6 16:00 ET
  • 2.130
  • 0.0000.00%
Post 20:01 ET
7.78MMarket Cap-714P/E (TTM)

About Pulmatrix Company

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.

Company Profile

SymbolPULM
Company NamePulmatrix
Listing DateMar 21, 2014
Founded2003
CEOMr. Peter Ludlum
MarketNASDAQ
Employees22
Fiscal Year Ends12-31
Address945 Concord Street,Suite 1217
CityFramingham
ProvinceMassachusetts
CountryUnited States of America
Zip Code01701
Phone1-888-355-4440

Company Executives

  • Name
  • Position
  • Salary
  • Peter Ludlum
  • Interim Chief Executive Officer, Interim Chief Financial Officer and Principal Accounting Officer
  • 398.58K
  • Michael J. Higgins
  • Chairman of the Board
  • 96.53K
  • Dr. Richard P. Batycky, PhD
  • Independent Director
  • 60.91K
  • Todd Bazemore
  • Independent Director
  • 59.41K
  • Christopher Cabell, M.D.
  • Independent Director
  • 51.91K
  • Anand Varadan
  • Independent Director
  • 46.91K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data